Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents 
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
SOMERSET, N.J., Oct. 02, 2017 -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP) a provider of proprietary, cloud-based healthcare IT solutions and services, announced today that it has made its final payment of $5 million, plus interest, related to the MediGain transaction.
“On September 28, 2017, MTBC paid Prudential $5,270,000, comprised of principal and accrued interest due related to the MediGain transaction,” explained MTBC in the 8-K filed with the Securities and Exchange Commission on October 2, 2017. It continued, “MTBC’s September 28th payment constituted payment in full of MTBC’s obligation to Prudential.”
“We were pleased to announce last month that we had fully repaid our Opus Bank term debt well ahead of the maturity date and we are likewise pleased today to announce the full satisfaction of our MediGain acquisition consideration,” said Stephen Snyder, MTBC President. He continued, “The repayment of our debt, combined with our significant year-over-year revenue growth and record Adjusted EBITDA, leaves us well positioned as we continue to grow and consolidate our segment of the market.”
Additional information regarding MTBC’s final payment is included with its Current Report on Form 8-K filed with the Securities and Exchange Commission on October 2, 2017, and is incorporated herein by reference.
About MTBC
MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based and mobile health solutions, together with related business services, to healthcare providers throughout the United States. Its integrated SaaS platform helps its customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For more information on MTBC, please visit www.mtbc.com.
Follow MTBC on TWITTER, LINKEDIN and FACEBOOK.
SOURCE MTBC
Company and Investor Contact: Bill Korn Chief Financial Officer Medical Transcription Billing, Corp. [email protected] (732) 873-5133
